BioSpace News Archive

Business

Retrophin Announces Appointment of Peter Heerma as Chief Commercial Officer

Retrophin, Inc. announced the appointment of Peter Heerma as chief commercial officer, effective immediately.

October 2, 2019
·
6 min read
New data presented on ASLAN’s varlitinib at ESMO 2019

ASLAN Pharmaceuticals announced the presentation of new data from a phase 1b open-label, dose escalation study of varlitinib in combination with modified irinotecan and infusional 5-fluorouracil chemotherapy to determine the safety, tolerability and maximum tolerated dose in advanced solid tumours.

October 2, 2019
·
4 min read
Novadip Biosciences Presents Clinical Case Study on Next Generation Tissue Regeneration Therapy for Critical Size Bone Reconstruction at EORS Conference

Novadip Biosciences will present a case study highlighting the results of a scaffold-free, 3-dimensional autologous cell therapy for the treatment of critical size bone reconstruction at the European Orthopaedic Research Society 2019 conference in Maastricht, The Netherlands.

October 2, 2019
·
3 min read
Genetown

resTORbio Presents New Findings on RTB101 During Late-Breaking Session at IDWeek 2019

Analysis indicates RTB101 upregulates innate antiviral immunity to prevent clinically symptomatic respiratory illnesses caused by multiple viruses in older adults

October 2, 2019
·
4 min read
Policy

Heidelberg Pharma AG Announces Adjustment of Guidance

Heidelberg Pharma AG announced that it has adjusted its guidance for the current fiscal year published in March 2019.

October 2, 2019
·
3 min read
Biotech Bay

GBT Announces Upcoming Presentations at the 47th Annual National Sickle Cell Disease Association of America (SCDAA) Convention

Global Blood Therapeutics, Inc. announced that four abstracts related to its sickle cell disease research have been accepted for oral and poster presentations during the 47th Annual National Sickle Cell Disease Association of America Convention in Baltimore, taking place October 9-12, 2019.

October 2, 2019
·
7 min read
Eisai Chooses Genedata Screener® for Fast and Reliable Assay Analysis

Industry’s most widely used platform for screening data analysis accelerates Eisai’s novel drug discovery

October 2, 2019
·
4 min read
Biotech Bay

Ultragenyx to Present at Jefferies Gene Therapy/Editing Summit

Ultragenyx Pharmaceutical Inc. announced that Emil Kakkis, the company’s Chief Executive Officer and President will present at the Jefferies Gene Therapy/Editing Summit on Tuesday, October 8, 2019 at 9:45 AM ET in New York, NY.

October 2, 2019
·
1 min read
Business

IBA receives down payment for Proteus®PLUS contract in Shenzhen, China

Seven proton therapy rooms already sold by IBA this year

October 2, 2019
·
2 min read
Drug Development

IXALTIS presents positive results from phase 2 studies for its lead compound Litoxetine, a potential “first in class” treatment for urinary incontinence

IXALTIS presents positive results from phase 2 studies for its lead compound Litoxetine, a potential “first in class” treatment for urinary incontinence.

October 2, 2019
·
2 min read